Does higher cardiovascular response to ECT predict early antidepressant effect?

Saravanan, E. S. M.; Gangadhar, Bangalore N.; Janakiramaiah, N.; Pandey, Ravi Shankar; Murthy, H.S. Niranjana; Dk, Subbakrishna

doi:10.1016/s0165-0327(00)00383-9

Cited by 20 publications

(10 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Earlier studies have reported that frontal origin of the electrical waves is probably associated with better generalisation of seizure in primary epilepsy[18] and better generalisation is associated with better outcome. [19] We hypothesise that the good response in our patient was probably due to better seizure generalisation with BF-ECT. A randomised double-blind controlled trial of BT-ECT versus BF-ECT in schizophrenia done at our institute showed significantly more improvement in psychotic symptoms in patients receiving BF-ECT.…”

Section: Discussionmentioning

confidence: 92%

Bifrontal ECT for drug-induced psychosis in Parkinson′s disease

Muralidharan

Thimmaiah

Chakraborty

et al. 2011

Indian J Psychiatry

View full text Add to dashboard Cite

Psychosis has been documented to occur during treatment for idiopathic Parkinson's disease (PD). This case report describes an elderly male who developed psychosis during the course of treatment for idiopathic PD. He was treated with clozapine but experienced significant adverse effects without clinical improvement. He was prescribed bifrontal electroconvulsive therapy (BF-ECT). Here, we report the efficacy of BF-ECT in treating psychosis and motor symptoms in PD, without producing cognitive side effects in an elderly male.

show abstract

Section: Discussionmentioning

confidence: 92%

Bifrontal ECT for drug-induced psychosis in Parkinson′s disease

Muralidharan

Thimmaiah

Chakraborty

et al. 2011

Indian J Psychiatry

View full text Add to dashboard Cite

show abstract

“…[ 48 ] However, atropine could mask the differential cardiovascular responses of the effective and ineffective seizures. [ 49 ]…”

Section: Cardiovascular System Monitoringmentioning

confidence: 99%

Two decades of an indigenously developed brief-pulse electroconvulsive therapy device: A review of research work from National Institute of Mental Health and Neurosciences

Sinha

Shyamsundar

Thirthalli

et al. 2016

Indian J Psychiatry

View full text Add to dashboard Cite

In 1993, a device to administer brief-pulse electroconvulsive therapy was indigenously developed through collaboration between the National Institution for Quality and Reliability and the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India. The additional feature of computerized recording of the electroencephalograph and electrocardiograph for both online and offline use had substantial clinical and research implications. Over the past two decades, this device has been used extensively in different academic and nonacademic settings. A considerable body of research with clinical and heuristic interest has also emanated using this device. In this paper, we present the development of this device and follow it up with a review of research conducted at NIMHANS that validate the features and potentials of this device.

show abstract

“…It is very difficult to predict the effect of ECT, but some studies indicate that postictal cardiovascular responses, which included heart rate, blood pressure and rate pressure product (RPP), predicted the therapeutic efficacy of ECT for depression. 36,37 In addition, five of 24 patients (21%) had cardiovascular complications. This percentage is similar to previous reports that showed rates of 7-27%.…”

Section: Does Higher Cardiovascular Response To Ect Predict Early Antmentioning

confidence: 99%

“…However, an increase of the RPP with atropine does not change the effect of ECT. 36 Controlling the catecholamine response might not attenuate the effect of ECT. To prevent cardiovascular complications, including takotsubo cardiomyopathy, we should control catecholamine levels.…”

Section: Does Higher Cardiovascular Response To Ect Predict Early Antmentioning

confidence: 99%

Urine catecholamine levels are not influenced by electroconvulsive therapy in depression or schizophrenia over the long term

Ito

Hatta

Usui

et al. 2012

Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Aim: Change in catecholamine seems to be associated with not only effects of electroconvulsive therapy (ECT), but also adverse events associated with ECT. Our aim in this study was to investigate whether or not ECT influences the concentration of catecholamine over the long term. Patients with a major depressive episode or schizophrenia, diagnosed according to DSM-IV criteria, who were newly admitted to Juntendo University Hospital to receive ECT, were recruited.Methods: Urine was collected during the 24 h before the first ECT treatment, during the 24 h after the first ECT treatment, during the 24 h after the final ECT treatment and during the 24 h 1 week after the final ECT treatment. Heart rate, the Hamilton Rating Scale for Depression and the Positive and Negative Syndrome Scale were assessed before and after ECT.Results: Twenty-four patients were included in the final sample, which consisted of 14 patients with major depressive episodes and 10 patients with schizophrenia. Abnormal electrocardiograms were indicated in four patients with depression during the ECT operation but all recovered naturally. There were no significant differences in the levels of dopamine, adrenaline or noradrenaline the day before the first ECT, a day after the first ECT, a day after the final ECT and a week after the final ECT. Conclusion:These results suggest that ECT does not alter urine catecholamine levels after ECT over the long term. Further studies will be required to confirm these findings in a larger sample of patients.

show abstract

Does higher cardiovascular response to ECT predict early antidepressant effect?

Cited by 20 publications

References 14 publications

Bifrontal ECT for drug-induced psychosis in Parkinson′s disease

Bifrontal ECT for drug-induced psychosis in Parkinson′s disease

Two decades of an indigenously developed brief-pulse electroconvulsive therapy device: A review of research work from National Institute of Mental Health and Neurosciences

Urine catecholamine levels are not influenced by electroconvulsive therapy in depression or schizophrenia over the long term

Contact Info

Product

Resources

About